As Her Oral Contraceptive Needs Change, Her Source Doesn't Have To
Zovia 1/50E
Making Informed Choices
A Choice For Nursing Mothers
Watson Choices In Oral Contraceptives
Contact Us
Oral Contraceptives Home
 
Search Go
Physician Prescribing Information
Patient Prescribing Information  
- Therapeutically bioequivalent to Demulen®* 1
- Available with 50 mcg ethinyl estradiol
- Competitively priced
- If you prescribe Demulen®*, you can choose Zovia

SAFETY INFORMATION
Women who use oral contraceptives (OCs) should be strongly advised not to smoke due to the increased risk of cardiovascular side effects. Serious risks reported with the use of OCs include blood clots, stroke, and heart attacks. OCs are contraindicated in women with thrombophlebitis, thromboembolic disorders, breast cancer, hepatic or estrogen-dependent neoplasia, cerebrovascular or coronary artery disease, jaundice, or undiagnosed genital bleeding. OCs do not protect against HIV infection (AIDS) or other sexually transmitted diseases.

Please see full Prescribing Information.
* Brand names are the trademarks of the product's manufacturers and/or owners.
Reference: 1. Data on file, Watson Pharma, Inc.

Watson Pharmaceuticals, Inc.
Site Last Updated: 2006-06-23
This site is intended for US residents only. Copyright © 2003 - 2009 Watson Pharma, Inc. All rights reserved.
Terms of Use
Legal/Copyright Disclaimer Privacy Policy